Director at IBEX (IBEX) receives 2,083-share restricted stock unit grant

Rhea-AI Filing Summary

Ballou-Aares Daniella reported acquisition or exercise transactions in this Form 4 filing.

IBEX Ltd director Daniella Ballou-Aares received an equity award of 2,083 common shares in the form of restricted stock units. The RSUs were granted at no cash cost and increase her direct holdings to 17,143 common shares. Twenty-five percent of the RSUs vest on July 1, 2026, with the remaining 75% vesting in equal annual installments over the following three years, contingent on her continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ballou-Aares Daniella

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	03/02/2026		A		2,083(1)	A	$0(1)	17,143	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on July 1, 2026, with 25% of the RSUs vesting annually thereafter for the following three years, provided that the Reporting Person remains in continuous service on each vesting date.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did IBEX (IBEX) report for Daniella Ballou-Aares?

IBEX reported that director Daniella Ballou-Aares acquired 2,083 restricted stock units, each representing one common share. The award was recorded at a price of $0.00 per share, reflecting an equity grant rather than an open-market purchase.

How many IBEX (IBEX) shares does Daniella Ballou-Aares hold after this Form 4?

Following the award, Daniella Ballou-Aares directly holds 17,143 common shares of IBEX Ltd. This total includes the effect of the 2,083 restricted stock units reported in the Form 4 insider filing for the specified transaction date.

What are the vesting terms of the IBEX (IBEX) restricted stock units granted?

The 2,083 restricted stock units vest over four years. 25% vest on July 1, 2026, and an additional 25% vests on each of the next three yearly anniversaries, conditioned on continuous service through each vesting date.

Was the IBEX (IBEX) director stock award a cash purchase?

No, the award was not a cash purchase. The Form 4 lists a transaction price of $0.00 per share, indicating the 2,083 restricted stock units were granted as compensation rather than bought in the open market.

Is the IBEX (IBEX) restricted stock unit grant held directly or indirectly?

The filing shows the award as direct ownership by Daniella Ballou-Aares. The Form 4 marks the ownership type as “D” (direct), and no footnote attributes the shares to any separate trust, partnership, or related entity.